Why life science companies must go beyond audits In today’s volatile world, supplier risk management is no longer just a compliance checkbox, it’s a business-critical priority. From geopolitical instability to climate disruption and regulatory shifts, pharmaceutical supply chains are under increasing strain. But while the industry has long excelled at reacting to problems, anticipating them remains a challenge.
In a new PharmaSource podcast, “Beyond Auditing: How Qualifyze Proactively Manages Risk in Uncertain Times,” David Schneider, CEO of Qualifyze, and Martin Lehmann, Chief Product Officer, explain how the industry can shift from reactive firefighting to proactive risk prevention.
A Strategic Shift: From Efficiency to Resilience Until recently, efficiency drove supply chain design. Today, resilience has become the name of the game. That means having networks that can flex, recover, and adapt—not just deliver the lowest cost. But to build this kind of resilience, companies need more than audits. They need actionable intelligence across their entire supplier base.
Why Data Silos Are Holding You Back A major barrier? Siloed data across quality, procurement, and supply chain teams. Many organizations still operate in isolation—making decisions based solely on internal insights. This narrow view increases the risk of surprises and missed red flags. Leading companies are changing that by integrating systems and using shared data to drive better decisions. It’s not just about collecting information—it’s about connecting it.
The CDMO Challenge For Contract Development and Manufacturing Organizations (CDMOs), the pressure is particularly high. They must navigate diverse client demands, tight margins, longer supply chains, and growing regulatory scrutiny. “CDMOs are being pulled in different directions,” David notes. “And without digital tools and better visibility, these challenges will only grow.”
How Qualifyze can help With over 4,000 audits completed and 1,500+ clients served, Qualifyze has built one of the most comprehensive supplier risk datasets in the industry. What started as an audit company is now a predictive intelligence platform, helping pharma companies spot and address risks before they escalate. “True success,” says David, “is when our clients prevent risks, not just react to them.” With Qualifyze’s platform, quality leaders can assess supplier risk at a glance. Procurement teams can benchmark vendors. Supply chain leaders can plan proactively.
Why You Should Listen This podcast is an insider look at how real companies are overcoming fragmentation, using data more effectively, and redefining what “quality” means in today’s supply chain. If you’re a quality professional, supply chain leader, or CDMO navigating uncertainty, this episode will help you understand:
- Why reactive models are failing
- How data can unify your teams
- What industry leaders are doing differently
- How Qualifyze can help you stay ahead
🎧 Don’t miss this conversation, listen to the podcast now and learn how to future-proof your supplier risk strategy. Click here to tune in.